DIEGO PEDROZA

AddressOne Baylor Plaza
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    K99GM155594     (PEDROZA, DIEGO A)Aug 1, 2024 - Jul 31, 2026
    NIH
    Characterization of the metastatic TIME by subcellular spatial profiling
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Yuan X, Hao X, Chan HL, Zhao N, Pedroza DA, Liu F, Le K, Smith AJ, Calderon SJ, Lieu N, Soth MJ, Jones P, Zhang XH, Rosen JM, Yuan X, Hao X, Chan HL, Zhao N, Pedroza DA, Liu F, Le K, Smith AJ, Calderon SJ, Lieu N, Soth MJ, Jones P, Zhang XH, Rosen JM. CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer. JCI Insight. 2024 Sep 17; 9(20). PMID: 39287984; PMCID: PMC11533985.
      Citations:    Fields:    Translation:HumansAnimalsCells
    2. Subramani R, Chatterjee A, Pedroza DA, Poudel S, Rajkumar P, Annabi J, Penner E, Lakshmanaswamy R. 2-methoxyestradiol inhibits the malignant behavior of triple negative breast cancer cells by altering their miRNome. Front Oncol. 2024; 14:1371792. PMID: 39328201; PMCID: PMC11424607.
      Citations:    
    3. Pedroza DA, Gao Y, Zhang XH, Rosen JM. Leveraging preclinical models of metastatic breast cancer. Biochim Biophys Acta Rev Cancer. 2024 09; 1879(5):189163. PMID: 39084494; PMCID: PMC11390310.
      Citations:    Fields:    Translation:HumansAnimals
    4. Yuan X, Hao X, Chan HL, Zhao N, Pedroza DA, Liu F, Le K, Smith AJ, Calderon SJ, Lieu N, Soth MJ, Jones P, Zhang XH, Rosen JM. CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC. bioRxiv. 2024 Apr 27. PMID: 38712292; PMCID: PMC11071628.
      Citations:    
    5. Zhao N, Kabotyanski EB, Saltzman AB, Malovannaya A, Yuan X, Reineke LC, Lieu N, Gao Y, Pedroza DA, Calderon SJ, Smith AJ, Hamor C, Safari K, Savage S, Zhang B, Zhou J, Solis LM, Hilsenbeck SG, Fan C, Perou CM, Rosen JM. Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. J Clin Invest. 2023 12 15; 133(24). PMID: 37874652; PMCID: PMC10721161.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    6. Zhao N, Kabotyanski EB, Saltzman AB, Malovannaya A, Yuan X, Reineke LC, Lieu N, Gao Y, Pedroza DA, Calderon SJ, Smith AJ, Hamor C, Safari K, Savage S, Zhang B, Zhou J, Solis LM, Hilsenbeck SG, Fan C, Perou CM, Rosen JM. Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. bioRxiv. 2023 Sep 28. PMID: 37808840; PMCID: PMC10557675.
      Citations:    
    7. Singh S, Lee N, Pedroza DA, Bado IL, Hamor C, Zhang L, Aguirre S, Hu J, Shen Y, Xu Y, Gao Y, Zhao N, Chen SH, Wan YW, Liu Z, Chang JT, Hollern D, Perou CM, Zhang XHF, Rosen JM. Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer. Cancer Res. 2022 06 15; 82(12):2281-2297. PMID: 35442423; PMCID: PMC9219596.
      Citations:    Fields:    Translation:HumansAnimalsCells
    8. Pedroza DA, Ramirez M, Rajamanickam V, Subramani R, Margolis V, Gurbuz T, Estrada A, Lakshmanaswamy R. miRNome and Functional Network Analysis of PGRMC1 Regulated miRNA Target Genes Identify Pathways and Biological Functions Associated With Triple Negative Breast Cancer. Front Oncol. 2021; 11:710337. PMID: 34350123; PMCID: PMC8327780.
      Citations: 1     
    9. Subramani R, Estrada A, Dixon M, Parada M, Rodriguez S, Pedroza DA, Ramirez MD, Clift A, Garcia L, Lakshmanaswamy R. Pregnancy Inhibits Mammary Carcinogenesis by Persistently Altering the Hypothalamic-Pituitary Axis. Cancers (Basel). 2021 Jun 26; 13(13). PMID: 34206988; PMCID: PMC8267621.
      Citations: 2     
    10. Pedroza DA, Subramani R, Tiula K, Do A, Rashiraj N, Galvez A, Chatterjee A, Bencomo A, Rivera S, Lakshmanaswamy R. Crosstalk between progesterone receptor membrane component 1 and estrogen receptor a promotes breast cancer cell proliferation. Lab Invest. 2021 06; 101(6):733-744. PMID: 33903732.
      Citations: 3     Fields:    Translation:HumansCells
    11. Subramani R, Medel J, Flores K, Perry C, Galvez A, Sandoval M, Rivera S, Pedroza DA, Penner E, Chitti M, Lakshmanaswamy R. Hepatocyte nuclear factor 1 alpha influences pancreatic cancer growth and metastasis. Sci Rep. 2020 11 19; 10(1):20225. PMID: 33214606; PMCID: PMC7678871.
      Citations: 1     Fields:    Translation:HumansCells
    12. Pedroza DA, Subramani R, Lakshmanaswamy R. Classical and Non-Classical Progesterone Signaling in Breast Cancers. Cancers (Basel). 2020 Aug 27; 12(9). PMID: 32867363; PMCID: PMC7563480.
      Citations: 12     
    13. Pedroza DA, Rajamanickam V, Subramani R, Bencomo A, Galvez A, Lakshmanaswamy R. Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling. Br J Cancer. 2020 10; 123(8):1326-1335. PMID: 32704174; PMCID: PMC7553958.
      Citations: 14     Fields:    Translation:HumansCells
    14. Subramani R, Camacho FA, Levin CI, Flores K, Clift A, Galvez A, Terres M, Rivera S, Kolli SN, Dodderer J, Miranda M, Rodriguez A, Pedroza DA, Chatterjee A, Lakshmanaswamy R. FOXC1 plays a crucial role in the growth of pancreatic cancer. Oncogenesis. 2018 Jul 06; 7(7):52. PMID: 29976975; PMCID: PMC6033944.
      Citations: 11     
    15. Subramani R, Nandy SB, Pedroza DA, Lakshmanaswamy R. Role of Growth Hormone in Breast Cancer. Endocrinology. 2017 06 01; 158(6):1543-1555. PMID: 28379395.
      Citations: 23     Fields:    Translation:HumansAnimals
    16. Nandy SB, Arumugam A, Subramani R, Pedroza D, Hernandez K, Saltzstein E, Lakshmanaswamy R. MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the Hippo signaling pathway. Oncotarget. 2015 Jul 10; 6(19):17366-78. PMID: 25962054; PMCID: PMC4627314.
      Citations: 30     Fields:    Translation:HumansCells
    17. Pedroza DA, De Leon F, Varela-Ramirez A, Lema C, Aguilera RJ, Mito S. The cytotoxic effect of 2-acylated-1,4-naphthohydroquinones on leukemia/lymphoma cells. Bioorg Med Chem. 2014 Jan 15; 22(2):842-7. PMID: 24368029; PMCID: PMC4215946.
      Citations: 4     Fields:    Translation:HumansCells
    PEDROZA's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (59)
    Explore
    _
    Co-Authors (8)
    Explore
    _
    Similar People (60)
    Explore
    _